Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 12/20 | 0.75 |
| ▸ | CA1 | P00915 | 11/20 | 0.75 |
| ▸ | CA12 | O43570 | 9/20 | 0.75 |
| ▸ | CA9 | Q16790 | 9/20 | 0.75 |
| ▸ | CA7 | P43166 | 1/20 | 0.60 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.57 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.56 |
| ▸ | CA4 | P22748 | 1/20 | 0.55 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.55 |
| ▸ | APP | P05067 | 1/20 | 0.54 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL283769 | 0.87 | CA2 (1.00) | CA2CA1CA12CA9CA7 | |
| SCHEMBL11023570 | 0.84 | CA2 (0.95) | CA2CA1CA12CA9CA7 | |
| Hydrochloric Acid SCHEMBL29969444 | 0.84 | CA2 (0.95) | CA2CA1CA12CA9CA7 | |
| SCHEMBL22243575 | 0.78 | CA12 (0.63) | CA2CA1CA12CA9CA7 | |
| SCHEMBL5867219 | 0.77 | CA2 (0.68) | CA2CA1CA12CA9CA7 | |
| SCHEMBL673609 | 0.76 | APP (0.74) | CA2CA1CA12CA9CA4 | |
| SCHEMBL14400750 | 0.76 | APP (0.74) | CA2CA1CA12CA9CA4 | |
| SCHEMBL5067825 | 0.76 | CA12 (0.58) | CA2CA1CA12CA9APP | |
| SCHEMBL5527294 | 0.75 | CA2 (0.75) | CA2CA1CA12CA9CA7 | |
| SCHEMBL22029399 | 0.75 | CA2 (0.75) | CA2CA1CA12CA9CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3893934-B1 | INSULIN CONJUGATES | SANOFI SA (FR) | 2025-09-10 | — | — | EP | disclosed |
| US-20250206798-A1 | INSULIN CONJUGATES | SANOFI SA (FR) | 2025-06-26 | — | — | US | disclosed |
| US-12195510-B2 | Insulin conjugates | SANOFI (FR) | 2025-01-14 | — | — | US | disclosed |
| US-20220048968-A1 | INSULIN CONJUGATES | SANOFI (FR) | 2022-02-17 | — | — | US | disclosed |
| US-20220048968-A1 | INSULIN CONJUGATES | SANOFI (FR) | 2022-02-17 | — | — | US | disclosed |
| EP-3894391-A1 | PEPTIDE BINDER | SANOFI (FR) | 2021-10-20 | — | — | EP | disclosed |
| EP-3893934-A1 | INSULIN CONJUGATES | SANOFI (FR) | 2021-10-20 | — | — | EP | disclosed |
| CN-113423691-A | Peptide binding agents | 赛诺菲 | 2021-09-21 | — | — | CN | disclosed |
| CN-113395982-A | Insulin conjugates | 赛诺菲 | 2021-09-14 | — | — | CN | disclosed |
| WO-2020120463-A1 | INSULIN CONJUGATES | SANOFI (FR) | 2020-06-18 | — | — | WO | disclosed |
| WO-2020120479-A1 | PEPTIDE BINDER | SANOFI (FR) | 2020-06-18 | — | — | WO | disclosed |
| WO-2020120479-A1 | PEPTIDE BINDER | SANOFI (FR) | 2020-06-18 | — | — | WO | disclosed |
| WO-2020120463-A1 | INSULIN CONJUGATES | SANOFI (FR) | 2020-06-18 | — | — | WO | disclosed |
| US-20200181223-A1 | INSULIN CONJUGATES | SANOFI (FR) | 2020-06-11 | — | — | US | disclosed |
| US-20200181223-A1 | INSULIN CONJUGATES | SANOFI (FR) | 2020-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200181223-A1 | INSULIN CONJUGATES | IAPP, INSR, IGF1R | CA2 1521/4885CA1 1162/4885CA12 453/4885 |
| US-20220048968-A1 | INSULIN CONJUGATES | IAPP, INSR, IGF1R | CA2 1521/4885CA1 1162/4885CA12 453/4885 |
| US-12195510-B2 | Insulin conjugates | IAPP, INSR, IGF1R | CA2 1521/4885CA1 1162/4885CA12 453/4885 |
| US-20250206798-A1 | INSULIN CONJUGATES | IAPP, INSR, IGF1R | CA2 1521/4885CA1 1162/4885CA12 453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.